Pre-operative Steroids in CRSsP

Sponsor
Loma Linda University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05095961
Collaborator
(none)
200
2
12

Study Details

Study Description

Brief Summary

Randomized controlled trial to determine the effectiveness of a five-day course of pre-operative oral steroids on decreasing intra-operative blood loss during endoscopic sinus surgery.

Detailed Description

The study will be a randomized cohort study, and patients will be recruited before surgery. Following randomization, patients will be given either a course of Prednisone (30 milligrams per day for 5 days, to be started five days prior to surgery) or no additional pre-operative prescriptions besides what is clinically determined by their treating physician. Patients will be scheduled for surgery and undergo functional endoscopic sinus surgery with timing as clinically indicated.

During endoscopic sinus surgery, surgical video will be recorded and stored on encrypted, flash drives with unique, non PHI, indicators to identify drives. Subsequently, each video will be graded by two, blinded surgeons for field visualization and thoroughness of dissection. Intra-operative blood loss will also be recorded. Post-operative data through 30 days post-operatively will be collected including: post-operative complications, resolution of symptoms, and nasal crusting during post-operative follow up. Following completion of data collection, these data will be analyzed by a separate, blinded investigator.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patient's will be randomized to one of two groups: pre-operative oral steroids or no controlPatient's will be randomized to one of two groups: pre-operative oral steroids or no control
Masking:
Single (Outcomes Assessor)
Masking Description:
Clinicians grading blood loss and surgical field disability on the recorded video footage will be blinded to patient identity and group status. Data analysis will be done by a blinded assessor.
Primary Purpose:
Treatment
Official Title:
Effect of Pre-operative Oral Steroids on Blood Loss in Endoscopic Sinus Surgery for Chronic Rhinosinusitis Without Polyps
Anticipated Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Feb 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Pre-operative oral steroids

Patients will be given a course of oral prednisone (30mg daily) for 5 days.

Drug: Prednisone
5 day course of oral prednisone pre-operatively. 30mg per day.

No Intervention: Control

No pre-operative medication will be prescribed

Outcome Measures

Primary Outcome Measures

  1. Intra-operative blood loss - 1 [Intra-operative]

    Measured intra-operative blood loss (in milliliters) as assessed by standard measure (total of blood in the suction canister [less the irrigation used])

  2. Intra-operative blood loss - 2 [Intra-operative]

    Blinded assessors grading of blood loss (in milliliters) as assessed by standard measure (total of blood in the suction canister [less the irrigation used])

  3. Surgical field visibility [Intra-operative]

    Blinded assessor's grading of surgical field visualization

Secondary Outcome Measures

  1. Patient intolerance of steroids [Pre-operative]

    Patient report of intolerable adverse effects of pre-operative steroids

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients between the ages of 18 and 99 years of age with a diagnosis of chronic rhinosinusitis without polyps who are being scheduled for functional endoscopic sinus surgery
Exclusion Criteria:
  • Patients under 18 years old, patients with a condition in which the use of systemic corticosteroids is contraindicated (poorly controlled diabetes mellitus, poorly controlled hypertension, active or untreated tuberculosis, active viral or fungal infection, acute angle glaucoma, osteoporosis, or acute congestive heart failure) patients allergic to corticosteroids, or, patients unwilling or unable to take the prescribed course of pre-operative steroids.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Loma Linda University

Investigators

  • Principal Investigator: Nadia Chan, MD, Loma Linda University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Loma Linda University
ClinicalTrials.gov Identifier:
NCT05095961
Other Study ID Numbers:
  • 5210327
First Posted:
Oct 27, 2021
Last Update Posted:
Apr 5, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 5, 2022